IBM Creates Nanotechnology to Battle Fungal Infections

Before scientists create something that has mainstream uses, it often starts as science fiction. A new technology deep within IBM’s (NYSE: IBM ) Singapore research facility isn’t quite ready for the mainstream but when it is, the implications for those who suffer from fungal infections and later, other infections, could